Localized drugs delivery hydroxyapatite microspheres for osteoporosis therapy

Proceedings of SPIE - The International Society for Optical Engineering

Volumn 8099, Issue , 2011, Pages

  Lee, J H ^a   Ko, I H ^a   Jeon, S H ^b   Chae, J H ^b   Lee, E J ^b   Chang, J H ^a  

^a Korea Institute of Ceramic Engineering and Technology (KICET)   (South Korea)

^b Prime Center   (South Korea)

Author keywords

Alendronate; BMP 2; Drug carrier; Hydroxyapatites; Localized delivery; Osteoporosis

Indexed keywords

ALENDRONATE; BMP-2; DRUG CARRIER; LOCALIZED DELIVERY; OSTEOPOROSIS;

APATITE; DRUG THERAPY; EMULSIFICATION; HYDROXYAPATITE; MEDICAL NANOTECHNOLOGY; SCANNING ELECTRON MICROSCOPY; SINTERING; UREA;

MICROSPHERES;

EID: 80054086708     PISSN: 0277786X     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.893014     Document Type: Conference Paper

References (24)

1. Hench, L.L., Polak, J.M., "Third-generation biomedical materials" Science 295, 1014-1017 (2002).
2. Veis, A., "A window on biomineralization" Science 307, 1419-1420 (2005).
3. Ellies, L.G., Carter, J.M., Natiella, J.R., Featherstone, J.D.B., Nelson, D.G.A., "Quantitative analysis of early in vivo tissue response to synthetic apatite implants" J Biomed Mater Res 22, 137-148 (1988).
4. De Lange, G.L., De Putter, C., De Wijs, F.L.J.A., "Histological and ultrastructual appearance of the hydroxyapatitebone interface" J Biomed Mater Res 24, 829-845 (1990).
5. Rossa, R., "Hydroxyapatite: reconstruction of facial bones" J Oral Implantol 17, 184-192 (1991).
6. Bonfield, W., Grynpas, M.D., Tully, A.E., Bowman, J., Abram, J., "Hydroxyapatite reinforced polyethylene-a mechanically compatible implant material for bone replacement" Biomaterials 2, 185-186 (1981).
7. Klein, C.A.P.T., Patka, P., den Hollander, W., "Macroporous calcium phosphate bioceramics in dog femora: a histological study of interface and biodegration" Biomaterials 10, 59-62 (1989).
8. Cai, Y., Liu, Y., Yan, W., Hu, Q., Tao, J., Zhang, M., Shi, Z., Tang, R., "Role of hydroxyapatite nanoparticle size in bone cell proliferation" J Mater Chem 17, 3780-3787 (2007).
9. Yuasa, T., Miyamoto, Y., Ishikawa, K., Takechi, M., Momota, Y., Tatehara, S., Nagayam, M., "Effects of apatite cements on proliferation and differentiation of human osteobkasts in vitro" Biomaterials 25, 1159-1166 (2004).
10. Cerroni, L., Filocamo, R., Fabbri, M., Piconi, C., Caropreso, S., Condò, S.G., "Growth of osteoblast-like cells on porous hydroxyapatite ceramics: an in vitro study" Biomol Eng 19, 119-124 (2002).
11. Granja, P.L., Silva, A.I.N., Borges, J.P., Barrias, C.C., Amaral, I.F., "Preparation and characterization of injectable chitosan-hydroxyapatite microspheres" Key Eng Mater 254-256, 573-576 (2004).
12. Matsumoto, T., Okazaki, M., Inoue, M., Yamaguchi, S., Kusunose, T., Toyonaga, T., Hamada, Y., Takahashi, J., "Hydroxyapatite particles as a controlled release carrier of protein" Biomaterials 25, 3807-3812 (2004).
13. Li, Y., Lee, P.I., "A new bioerodible system for sustained local drug delivery based on hydrolytically activated in situ macromolecular association" Int J Pharm 383, 45-52 (2010).
14. Kundu, B., Soundrapandian, C, Nandi, S.K., Mukherjee, P., Dandapat, N., Roy, S., Datta, B.K., Mandal, T.K., Basu, D., Bhattacharya, R.N., "Development of new localized drug delivery system based on ceftriaxone-sulbactam composite drug impregnated porous hydroxyapatite: A systematic approach for in vitro and in vivo animal trial" Pham Res 27, 1659-1676 (2010).
15. Hernandez, C.J., Beaupré, G.S., Marcus, R., Carter, D.R., "A theoretical analysis of the contributions of remodeling space, mineralization, and bone balance to changes in bone mineral density during alendronate treatment" Bone 29, 511-516 (2001).
16. Lin, J.H., Chen, I-W., delLuna, F.A., "On the absorption of alendronate in rats" J Pharm Sci 83, 1741-1746 (1994).
17. Gertz, B.J., Holland, S.D., Kline, W.F., Matuszewski, B.K., Porras, A.G., "Clinical pharmacology of alendronate sodium" Osteopor Int 3, 513-516 (1993).
18. Adami, S., Mian, M., Gatti, P., Rossini, M., Zamberlan, N., Bertoldo, F., Lo Cascio, V., "Effects of two oral doses of alendronate in the treatment of Paget's disease of bone" Bone 15, 415-417 (1994).
19. Huang, W., Wang, Y., Ren, I., Du, C., Shi, X., "A novel PHBV/HA microsphere releasing system loaded with alendronate" Mater Sci Eng 29, 2221-2225 (2009).
20. Shi, X., Wang, Y., Ren, L., Gong, Y., Wang, D-A., "Enhancing alendronate release from a novel PLGA/Hydroxyapatite microspheric system for bone repairing applications" Phar Res 26, 422-430 (2009).
21. Kim, C.W., Yun, Y., Lee, H.J., Hwang, Y., Kwon, I.K., Lee, S.C., "In situ fabrication of alendronate-loaded calcium phosphate microspheres: Controlled release for inhibition of osteoclastogenesis" J Control Release 147, 45-53 (2010).
22. Jokic, B., Tanaskovic, D., Jankovic-Castvan, I., Drmanic, S., Petrovic, R., "Synthesis of nanosized calcium hydroxyapatite particles by the catalytic decomposition of urea with urease" J Mater Res 22, 1156-1161 (2007).
23. Sasaki, A., Kitamura, K., Alcalde, R.E., Tanaka, T., Suzuki, A., Etoh, Y., Matsumura, T., "Effect of a newly developed bisphosphonate, YM529, on osteolytic bone metastases in nude mice" Int. J. Cancer 77, 279-285 (1998).
24. Boanini, E., Gazzano, M., Rubini, K., Bigi, A., "Composite nanocrystals provide new insight on alendronate interaction with hydroxyapatite structure" Adv. Mater. 19, 2499-2502 (2007).